Recombinant CD274 (Durvalumab Biosimilar) antibody (PE)

Catalog No. ABIN7867150

The PE-conjugated Humanized Monoclonal anti-CD274 (Durvalumab Biosimilar) antibody (ABIN7867150) specifically detects CD274 (Durvalumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant CD274 (Durvalumab Biosimilar) antibody (PE) (ABIN7867150)

Target: CD274 (Durvalumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD274 (Durvalumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-CD274 (Durvalumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-PDL1 (durvalumab biosimilar) mAb

Isotype: IgG1, K97R, L117F, L118E, P214S

Application Details

Application Notes: Flow Cyt 1 μL/test

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with,0.18 % BSA-0.1 %Proclin300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for CD274 (Durvalumab Biosimilar)

Target: CD274 (Durvalumab Biosimilar)

Alternative Name: durvalumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1,MEDI4736

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: Q9NZQ7